Cabaletta Bio, Inc.·4

Jan 21, 6:55 PM ET

Tomasello Shawn 4

4 · Cabaletta Bio, Inc. · Filed Jan 21, 2026

Research Summary

AI-generated summary of this filing

Updated

Cabaletta Bio (CABA) Director Shawn Tomasello Buys 22,725 Shares

What Happened

  • Shawn Tomasello, a director of Cabaletta Bio, reported a purchase of 22,725 shares on 2026-01-21. The shares were acquired at $2.21 per share for a total transaction value of approximately $50,322. This was reported as a purchase (transaction code P), indicating an insider buy rather than a sale.

Key Details

  • Transaction date and price: 2026-01-21; 22,725 shares at $2.21 each.
  • Total value: ≈ $50,322.
  • Transaction type: P = Purchase (reported as open-market or private purchase).
  • Shares owned after transaction: Not specified in the provided filing.
  • Filing timeliness: Reported and filed on 2026-01-21; no late filing indicated in the provided data.
  • Footnotes/other: No 10b5-1 plan, tax withholding, or other special footnotes were provided in the information given.

Context

  • Insider purchases can be more informative than sales because they may signal confidence in the company, but they are only one data point and do not prove future performance.
  • This was a direct purchase, not an option exercise, gift, or award.

Insider Transaction Report

Form 4
Period: 2026-01-21
Transactions
  • Purchase

    Common Stock

    2026-01-21$2.21/sh+22,725$50,32222,725 total(indirect: By LLC)
Signature
By: /s/ Michael Gerard, as Attorney-in-Fact|2026-01-21

Documents

1 file
  • 4
    ownership.xmlPrimary

    4